http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003278909-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71773c75881617b83d91f92c8dfd7792
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D293-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D421-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D421-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
filingDate 2003-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474d49984d3dd7ba66f3469745bceb3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c273c31aaadaf96efab54243f5c89a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19daf92dae090366f79df3fef69a3b7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ec4fa0c2cfe12996fe1d00c0052f87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2147f5a74d78c19422136586a92105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b71e5d24ca220ee8655fcb6037f87f2d
publicationDate 2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2003278909-A1
titleOfInvention The use of benzisoselenazolone compounds against ischemic myocardial damage
priorityDate 2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419741694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87081618

Total number of triples: 26.